CT-guided percutaneous microwave ablation of pulmonary malignancies: Results in 69 cases

被引:69
作者
Lu, Qiang [1 ]
Cao, Wei [2 ]
Huang, Lijun [1 ]
Wan, Yi [3 ,4 ]
Liu, Tonggang [5 ]
Cheng, Qingshu [1 ]
Han, Yong [1 ]
Li, Xiaofei [1 ]
机构
[1] Fourth Mil Med Univ, Tangdu Hosp, Dept Thorac Surg, Xian 710032, Peoples R China
[2] Fourth Mil Med Univ, Tangdu Hosp, Dept Intervent Radiol, Xian 710032, Peoples R China
[3] Fourth Mil Med Univ, Dept Hlth Stat, Xian 710032, Peoples R China
[4] Fourth Mil Med Univ, Inst Hlth Informat, Xian 710032, Peoples R China
[5] Fourth Mil Med Univ, Tangdu Hosp, Dept Resp, Xian 710032, Peoples R China
关键词
Percutaneous microwave coagulation therapy; Inoperable pulmonary malignancies; Survival rates; RADIOFREQUENCY ABLATION; LUNG MALIGNANCIES; FOLLOW-UP; THERAPY; RESECTION; CANCER; LIVER;
D O I
10.1186/1477-7819-10-80
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Background: Microwave ablation (MWA) has attracted a worldwide attention gradually in treating inoperable pulmonary malignancies. However, in the lung tissues treated with MWA recurrence of tumor may still occur and few data in large patient groups till now were reported about the safety or effectiveness of microwave ablation in treating primary lung cancer and metastatic pulmonary malignancies. The purpose of this study is to evaluate the clinical curative effect (local control, survival data) MWA and its safety as well. Methods: From 1 January 2005 to 1 January 2008, retrospective analyses, 69 patients underwent computed tomography (CT)-guided percutaneous MWA of pulmonary malignancies. All patients were deemed medically inoperable. The correlation of tumor sizes and local progression after ablation was analyzed and the survival rates within 3 years post surgery were compared between non-small-cell lung cancer and pulmonary metastases groups also. Results: Pneumothorax was the most frequent complication and occurred in 24.64% patients after ablation. Neither needle track implantation was found nor did patient death occur in these patients within 30 days. The 1-, 2-, and 3-year overall survival rates were 66.7%, 44.9% and 24.6%, respectively. The overall survival rates for NSCLC patients in 1 year, 2 years, and 3 years were 75.0%, 54.2%, and 29.2%, respectively. The overall survival rates for pulmonary metastatic tumor patients in 1 year, 2 years, and 3 years were 47.6%, 23.8%, and 14.3%, respectively. The recurrence-free survival rates for NSCLC patients in 1 year, 2 years, and 3 years were 72.9%, 50.0%, and 27.1%, respectively. The mortality rates for pulmonary metastatic tumor patients in 1 year, 2 years, and 3 years were 47.6%, 19.0%, and 14.3%, respectively. Conclusions: Percutaneous microwave coagulation therapy was one safe and effective method and could be beneficial for the improvement of inoperable pulmonary malignancies treatment effect.
引用
收藏
页数:7
相关论文
共 29 条
  • [11] Radiofrequency ablation for the treatment of non-small cell lung cancer in marginal surgical candidates
    Fernando, HC
    De Hoyos, A
    Landreneau, RJ
    Gilbert, S
    Gooding, WE
    Buenaventura, PO
    Christie, NA
    Belani, C
    Luketich, JD
    [J]. JOURNAL OF THORACIC AND CARDIOVASCULAR SURGERY, 2005, 129 (03) : 639 - 644
  • [12] Radiofrequency Ablation of a Spinal Osteoid Osteoma: Low Heat-load Technique
    Foulner, Deryck
    [J]. JOURNAL OF VASCULAR AND INTERVENTIONAL RADIOLOGY, 2010, 21 (10) : 1596 - 1598
  • [13] Microwave coagulation therapy in canine peripheral lung tissue
    Furukawa, K
    Miura, T
    Kato, Y
    Okada, S
    Tsutsui, H
    Shimatani, H
    Kajiwara, N
    Taira, M
    Saito, M
    Kato, H
    [J]. JOURNAL OF SURGICAL RESEARCH, 2005, 123 (02) : 245 - 250
  • [14] Gillams Alice, 2009, Cancer Imaging, V9 Spec No A, pS68, DOI 10.1102/1470-7330.2009.9028
  • [15] Image-guided Tumor Ablation: Standardization of Terminology and Reporting Criteria (Reprinted from J Vasc Interv Radiol, vol 16, pg 765-778, 2005)
    Goldberg, S. Nahum
    Grassi, Clement J.
    Cardella, John F.
    Charboneau, J. William
    Dodd, Gerald D., III
    Dupuy, Damian E.
    Gervais, Debra A.
    Gillams, Alice R.
    Kane, Robert A.
    Lee, Fred T., Jr.
    Livraghi, Tito
    McGahan, John
    Phillips, David A.
    Rhim, Hyunchul
    Silverman, Stuart G.
    Solbiati, Luigi
    Vogl, Thomas J.
    Wood, Bradford J.
    Vedantham, Suresh
    Sacks, David
    [J]. JOURNAL OF VASCULAR AND INTERVENTIONAL RADIOLOGY, 2009, 20 (07) : S377 - S390
  • [16] Ultrasonography-guided percutaneous microwave ablation of peripheral lung cancer
    He, Wen
    Hu, Xiang-Dong
    Wu, Dong-Fang
    Guo, Li
    Zhang, Li-Zhi
    Xiang, Dong-Ying
    Ning, Bin
    [J]. CLINICAL IMAGING, 2006, 30 (04) : 234 - 241
  • [17] Primary and secondary lung malignancies treated with percutaneous radiofrequency ablation: Evaluation with follow-up helical CT
    Jin, GY
    Lee, JM
    Lee, YC
    Han, YM
    Lim, YS
    [J]. AMERICAN JOURNAL OF ROENTGENOLOGY, 2004, 183 (04) : 1013 - 1020
  • [18] Complications of ablative therapies in lung cancer
    Padda, Sukhmani
    Kothary, Nishita
    Donington, Jessica
    Cannon, Walter
    Loo, Billy W., Jr.
    Kee, Stephen
    Wakelee, Heather
    [J]. CLINICAL LUNG CANCER, 2008, 9 (02) : 122 - 126
  • [19] Staging and the surgical management of lung cancer
    Park, BJ
    Louie, O
    Altorki, N
    [J]. RADIOLOGIC CLINICS OF NORTH AMERICA, 2000, 38 (03) : 545 - +
  • [20] Microwave Ablation of Lung Tissue: Impact of Single-Lung Ventilation on Ablation Size
    Santos, Ricardo S.
    Gan, Jianmin
    Ohara, Carl J.
    Daly, Benedict
    Ebright, Michael I.
    Desimone, Michael
    Fernando, Hiran C.
    [J]. ANNALS OF THORACIC SURGERY, 2010, 90 (04) : 1116 - 1120